Spyre Therapeutics, Inc.NASDAQ: SYRE

Spyre Therapeutics to Participate in Upcoming Investor Conferences

· Issued by Spyre Therapeutics, Inc. via GlobeNewswire

Summary by 6ix AI

Spyre Therapeutics, a clinical-stage biotechnology company (its treatments are being tested in clinical trials) developing immunology therapies, will have management take part in fireside chats (informal question-and-answer sessions) at four investor conferences between November 16 and December 2, 2026.

Key details

  • UBS Global Biopharma Conference in London on Monday, November 16, 2026, at 1:20 pm GMT; Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026, at 3:00 pm GMT.
  • 9th Annual Evercore Healthcare Conference in Miami on Tuesday, December 1, 2026, at 3:00 pm ET; Citi's 2026 Global Healthcare Conference in Miami on Wednesday, December 2, 2026, at 9:40 am ET.
  • Members of the management team will also hold one-on-one meetings with investors during the conferences, and live audio webcasts and replays of the events will be available on Spyre's investor events website.

6ix AI wrote this summary from the release below and checked it against the release.

WALTHAM, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients, today announced that management will participate in the following upcoming investor conferences in November and December:

Event: UBS Global Biopharma Conference – London
Date: Monday, November 16, 2026
Fireside Time: 1:20 pm GMT

Event: Jefferies Global Healthcare Conference – London
Date: Tuesday, November 17, 2026
Fireside Time: 3:00 pm GMT

Event: 9th Annual Evercore Healthcare Conference - Miami
Date: Tuesday, December 1, 2026
Fireside Time: 3:00 pm ET

Event: Citi’s 2026 Global Healthcare Conference - Miami
Date: Wednesday, December 2, 2026
Fireside Time: 9:40 am ET

Members of the Spyre management team will also host one-on-one investor meetings during the conferences.

Live audio webcasts and replays of these events will be available on the Spyre investor events website at https://ir.spyre.com/events-and-presentations.

About Spyre Therapeutics

Spyre Therapeutics is a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients. Spyre's pipeline includes investigational extended half-life antibodies targeting α4β7, TL1A, IL-23, and IL-17A/F as well as rational combination programs.

For more information, visit Spyre's website at www.spyre.com.

For Investors:     
Eric McIntyre, Spyre Therapeutics
SVP of Finance and Investor Relations
[email protected]

View original source (GlobeNewswire)Spyre Therapeutics, Inc. on 6ix

Story so far

Earlier from Spyre Therapeutics

All Spyre Therapeutics news releases